Incidence of refractory CMV infection with or without antiviral resistance in Spain: A systematic literature review

Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients

(2022) Marta Santos Bravo et al.   Microbiology Spectrum

Cytomegalovirus infection in transplant recipients: Newly approved additions to our armamentarium

(2022) Fareed Khawaja et al.   CLINICAL MICROBIOLOGY AND INFECTION

Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety

(2019) Brianne M. Ritchie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing

(2019) Rubén López-Aladid et al.   PLoS One

Estudio de resistencias de citomegalovirus en pacientes receptores de trasplante alogénico de progenitores hematopoyéticos

(2019) Alba Guiu et al.   MEDICINA CLINICA

Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?

(2018) Carlos Solano et al.   BONE MARROW TRANSPLANTATION

Drug-resistant cytomegalovirus

(2018) Raymund R. Razonable   Current Opinion in Organ Transplantation

Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials

(2018) Roy F Chemaly et al.   CLINICAL INFECTIOUS DISEASES

Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance

(2017) Rubén López-Aladid et al.   JOURNAL OF CLINICAL VIROLOGY

The “ABC” of Virus-Specific T Cell Immunity in Solid Organ Transplantation

(2016) M. Sester et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

(2016) J. Torre-Cisneros et al.   Transplantation Reviews

Monitoring of Trough Plasma Ganciclovir Levels and Peripheral Blood Cytomegalovirus (CMV)-Specific CD8+T Cells To Predict CMV DNAemia Clearance in Preemptively Treated Allogeneic Stem Cell Transplant Recipients

(2014) Estela Giménez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients

(2012) Marta Bodro et al.   LIVER TRANSPLANTATION

Incidence, Risk Factors, and Outcome of Cytomegalovirus Infection and Disease in Patients Receiving Prophylaxis with Oral Valganciclovir or Intravenous Ganciclovir after Umbilical Cord Blood Transplantation

(2009) Pau Montesinos et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Impacto de la carga vírica inicial de citomegalovirus sobre la eficacia del tratamiento anticipado con ganciclovir en receptores de trasplante de progenitores hematopoyéticos

(2009) Julián Torre-Cisneros et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Valganciclovir as Treatment for Cytomegalovirus Disease in Solid Organ Transplant Recipients

(2008) O. Len et al.   CLINICAL INFECTIOUS DISEASES